An improved catalytic system for the reduction of levulinic acid to γ-valerolactone

An improved bidentate phosphine-modified recyclable catalytic system was developed for the selective conversion of biomass- derived levulinic acid into γ-valerolactone with a TOF of 21 233 h−1 in solvent-, chlorine- and additive-free reaction environment

Ruthenium-catalyzed solvent-free conversion of furfural to furfuryl alcohol

Bidentate phosphine-modified Ru-based homogeneous catalyst systems were developed for solvent-free conversion of furfural to furfuryl alcohol as a versatile biomass-based C5-platform molecule. The effect of ligand structure, ligand concentration, operating pressure and reaction temperature on the catalyst's activity were studied in details. Under optimized conditions complete conversion of furfural to furfurol was achieved in the absence of any solvent and without by-product formation. The maximum turnover frequency (6273 h–1) and 100% atom economy were obtained by using homogeneous Ru/Ph2P(CH2)4PPh2 catalyst, which was recyclable for twelve consecutive runs without affecting catalytic performance of the catalyst

Direct asymmetric reduction of levulinic acid to gamma-valerolactone: synthesis of a chiral platform molecule

Levulinic acid was directly converted to optically active (S)-gamma-valerolactone, a proposed biomass-based chiral platform molecule. By using a SEGPHOS ligand-modified ruthenium catalyst in methanol as a co-solvent, eventually, 100% chemoselectivity, and 82% enantioselectivity were achieved. The effect of the catalyst composition and reaction parameters on the activity and selectivity was investigated in detail. The conversion of a “real” biomass derived levulinic acid to optically active GVL without decreasing the enantioselectivity was also demonstrated

Use of Gamma-Valerolactone as an Illuminating Liquid and Lighter Fluid

The sulfuric acid-catalyzed conversion of paper wastes in gamma-valerolactone (GVL) or dioxane leads to the formation of levulinic acid (LA) and formic acid (FA), which can be converted to GVL by transfer-hydrogenation using the Shvo catalyst in situ or separately. The isolation of LA and FA was assisted by the neutralization of the sulfuric acid with ammonia to form a biphasic system. While the ammonium sulfate and most of FA and some of LA were in the aqueous phase, the organic solvent-rich phase contained most of the LA and some of the FA. GVL was used as an illuminating liquid in glass lamps for hours without the formation of noticeable smoke and/or odor even in a small room. While neat GVL can be used for the safe but somewhat slow lighting of charcoal, the ignition with different mixtures of GVL (95 or 90 vol %) and ethanol (5 or 10 vol %) was reduced to a convenient few seconds. Ignition tests of charcoal combined with emission analyses revealed that by increasing the ethanol content to 10 vol % the relative VOC emission can be decreased by 15% compared to the commercial lighter fluids

Spatial risk assessment of hydrological extremities : Inland excess water hazard, Szabolcs-Szatmár-Bereg Country, Hungary

Inland excess water hazard was regionalized and digitally mapped using auxiliary spatial environmental information for a county in Eastern Hungary. Quantified parameters representing the effect of soil, geology, groundwater, land use and hydrometeorology on the formulation of inland excess water were defined and spatially explicitly derived. The complex role of relief was characterized using multiple derivatives computed from a DEM. Legacy maps displaying inland excess water events were used as a reference dataset. Regression kriging was applied for spatial inference with the correlation between environmental factors and inundation determined using multiple linear regressions. A stochastic factor derived through kriging the residual was added to the regression results,thus producing the final inundation hazard map. This may be of use for numerous landrelated activities

A step towards hydroformylation under sustainable conditions: platinum-catalysed enantioselective hydroformylation of styrene in gamma-valerolactone

Platinum-catalysed enantioselective hydroformylation of styrene was performed in γ-valerolactone (GVL) as a proposed environmentally benign reaction medium. Optically active bidentate ligands, possessing various types of chirality elements e.g. central (BDPP), axial (BINAP, SEGPHOS, DM-SEGPHOS, DTBM-SEGPHOS) and planar/central (JOSIPHOS) elements, were applied in in situ generated Pt-diphosphine-tin(II)chloride catalyst systems. In general, slightly higher activities and regioselectivities towards a branched aldehyde (2-phenylpropanal) were obtained in toluene as a reference conventional solvent. However, higher chemoselectivities towards aldehydes (up to 98%) in GVL were obtained at lower temperatures. The application of GVL proved to be also advantageous regarding enantioselectivity: although moderate enantioselectivities were obtained in both solvents, in most cases higher ee values were detected in GVL. From the mechanistic point of view, the formation of different catalytic intermediates and/or different kinetics can be envisaged from the different temperature dependences of ee in GVL and toluene. The 31P-NMR characterization of catalyst species in GVL was also provided

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed